IL13RA2 and cancer: However, LNCaP cancer cells, which normally express very low levels of IL-13Rα2, showed increased expression of IL-13Rα2 mRNA (Figure 5a) and protein (Figure 5b) and increased cell surface expression of IL-13Rα2 (Figure 5c) following treatment with TSA or 5-aza-dC.